The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time, and questions about who was enrolled in the trials. The MDMA...
Psychedelic guide matching is one of the most important decisions a seeker can make, and at JourneyOM, it is never left to an algorithm. This post explains how JourneyOM’s concierge model works, why the match matters as much as the medicine, and what to expect...
RFK Jr. psychedelic therapy support has brought real political attention to substances like psilocybin, MDMA, and ibogaine. For seekers already exploring this space, the shift matters. It does not, however, change what responsible engagement looks like at the...
Psychedelic therapy for veterans is one of the most actively researched areas in mental health today. Clinical trials involving MDMA and psilocybin have shown meaningful reductions in PTSD symptoms for people who found little relief through conventional care. This...
Psychedelic assisted therapy in Marin County is a growing area of interest, but the legal landscape is still evolving and the quality of available support varies widely. This guide explains what options exist today, what to look for in a guide, and why how you prepare...
Psychedelic assisted therapy in San Francisco is a growing field, but the legal landscape is complex and finding a safe, vetted guide takes real effort. This post walks you through what your options actually look like right now, what to expect from a well-supported...
